268 related articles for article (PubMed ID: 1406364)
1. Bacteriostatic and bactericidal activity of antituberculosis drugs against Mycobacterium tuberculosis, Mycobacterium avium-Mycobacterium intracellulare complex and Mycobacterium kansasii in different growth phases.
Yamori S; Ichiyama S; Shimokata K; Tsukamura M
Microbiol Immunol; 1992; 36(4):361-8. PubMed ID: 1406364
[TBL] [Abstract][Full Text] [Related]
2. [Bactericidal activities of rifampicin, ethambutol, enviomycin and streptomycin on Mycobacterium avium-Mycobacterium intracellulare complex strains].
Tsukamura M; Yamori S
Kekkaku; 1990 Aug; 65(8):519-25. PubMed ID: 2214513
[TBL] [Abstract][Full Text] [Related]
3. In vitro synergistic activity of ethambutol, isoniazid, kanamycin, rifampin, and streptomycin against Mycobacterium avium-intracellulare complex.
Zimmer BL; DeYoung DR; Roberts GD
Antimicrob Agents Chemother; 1982 Jul; 22(1):148-50. PubMed ID: 7125626
[TBL] [Abstract][Full Text] [Related]
4. Combined versus single antituberculosis drugs on the in vitro sensitivity patterns of non-tuberculous mycobacteria.
Banks J; Jenkins PA
Thorax; 1987 Nov; 42(11):838-42. PubMed ID: 3424264
[TBL] [Abstract][Full Text] [Related]
5. [Determination of the susceptibilities to antituberculosis agents in Mycobacterium avium-Mycobacterium intracellulare complex].
Tsukamura M
Kekkaku; 1990 Jul; 65(7):471-5. PubMed ID: 2214509
[TBL] [Abstract][Full Text] [Related]
6. Bactericidal activity of streptomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium Tuberculosis.
Dickinson JM; Aber VR; Mitchison DA
Am Rev Respir Dis; 1977 Oct; 116(4):627-35. PubMed ID: 411404
[TBL] [Abstract][Full Text] [Related]
7. [Chemotherapeutic regimens for nontuberculous mycobacterial infection based on in-vitro susceptibility test results].
Tsukamura M; Yamori S
Kekkaku; 1990 May; 65(5):349-57. PubMed ID: 2168003
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of minimal inhibitory concentration values of antituberculosis agents against Mycobacterium avium complex strains with incubation period].
Tsukamura M; Ichiyama S
Kekkaku; 1988 Feb; 63(2):107-10. PubMed ID: 3373933
[No Abstract] [Full Text] [Related]
9. Paradoxical effect of Tween 80 between the susceptibility to rifampicin and streptomycin and the susceptibility to ethambutol and sulfadimethoxine in the Mycobacterium avium-Mycobacterium intracellulare complex.
Yamori S; Tsukamura M
Microbiol Immunol; 1991; 35(10):921-6. PubMed ID: 1779893
[TBL] [Abstract][Full Text] [Related]
10. In vitro bactericidal activity of oxazolidinone, RBx 8700 against Mycobacterium tuberculosis and Mycobacterium avium complex.
Rao M; Sood R; Malhotra S; Fatma T; Upadhyay DJ; Rattan A
J Chemother; 2006 Apr; 18(2):144-50. PubMed ID: 16736882
[TBL] [Abstract][Full Text] [Related]
11. Superiority of enviomycin or streptomycin over ethambutol in initial treatment of lung disease caused by Mycobacterium avium complex.
Tsukamura M; Ichiyama S; Miyachi T
Chest; 1989 May; 95(5):1056-8. PubMed ID: 2539957
[TBL] [Abstract][Full Text] [Related]
12. In-vitro bacteriostatic and bactericidal activity of isoniazid on the Mycobacterium avium-Mycobacterium intracellulare complex.
Tsukamura M
Tubercle; 1990 Sep; 71(3):199-204. PubMed ID: 2238126
[TBL] [Abstract][Full Text] [Related]
13. MIC as a quantitative measurement of the susceptibility of Mycobacterium avium strains to seven antituberculosis drugs.
Heifets L
Antimicrob Agents Chemother; 1988 Aug; 32(8):1131-6. PubMed ID: 2461162
[TBL] [Abstract][Full Text] [Related]
14. [Bactericidal activity of antituberculosis drugs against Mycobacterium avium complex].
Tsukamura M
Kekkaku; 1990 Jan; 65(1):9-12. PubMed ID: 2313966
[TBL] [Abstract][Full Text] [Related]
15. In vitro drug sensitivity of M. avium-intracellulare complex in the presence and absence of dimethyl sulphoxide.
Nash DR; Steingrube VA
Microbios; 1982; 35(140):71-8. PubMed ID: 7162431
[TBL] [Abstract][Full Text] [Related]
16. Synergistic effects of antimycobacterial drug combinations on Mycobacterium avium complex determined radiometrically in liquid medium.
Hoffner SE; Svenson SB; Källenius G
Eur J Clin Microbiol; 1987 Oct; 6(5):530-5. PubMed ID: 3436314
[TBL] [Abstract][Full Text] [Related]
17. Combined vs. single-drug studies of susceptibilities of Mycobacterium kansasii to isoniazid, streptomycin, and ethambutol.
Tsang AY; Bentz RR; Schork MA; Sodeman TM
Am J Clin Pathol; 1978 Nov; 70(5):816-20. PubMed ID: 717288
[TBL] [Abstract][Full Text] [Related]
18. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs].
Tomioka H; Sato K; Saito H
Kekkaku; 1991 Jul; 66(7):489-92. PubMed ID: 1890791
[TBL] [Abstract][Full Text] [Related]
19. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT
J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568
[TBL] [Abstract][Full Text] [Related]
20. [In vitro susceptibility testing of nontuberculous mycobacteria to streptomycin, kanamycin and enviomycin].
Tsukamura M
Kekkaku; 1989 Sep; 64(9):557-62. PubMed ID: 2554046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
